Houston biotech firms resume trading after weeks-long suspensions
May 28, 2020 at 19:02 PM EDT
Regulators halted trading of the biotech firms' stock as they questioned claims made about potential treatments for the novel coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.